Yatai Pharm released its performance for the first three quarters, with a net profit attributable to the parent company of 97.195 million yuan, a year-on-year increase of 2909.49%
According to the Zhitong Finance APP, Yatai Pharm released its third-quarter report for 2025. In the first three quarters, the company achieved an operating income of 228 million yuan, a year-on-year decrease of 25.59%. The net profit attributable to shareholders of the listed company was 97.195 million yuan, a year-on-year increase of 2909.49%. The net loss attributable to shareholders of the listed company, after deducting non-recurring gains and losses, was 56.5853 million yuan
According to the Zhitong Finance APP, Yatai Pharm (002370.SZ) released its third-quarter report for 2025. In the first three quarters, the company achieved an operating income of 228 million yuan, a year-on-year decrease of 25.59%. The net profit attributable to shareholders of the listed company was 97.195 million yuan, a year-on-year increase of 2909.49%. The net loss attributable to shareholders of the listed company, after deducting non-recurring gains and losses, was 56.5853 million yuan
